Conferences

Following the tremendous response for Vaccines Summit Ohio 2021, Biogate Scientific Center brings to you the 2nd edition Vaccines Summit Boston 2022(VSBOSTON22) scheduled for March 28–30 2022 in Boston, MA. #VSBOSTON22 provides an iconic platform where science and business converge. It brings together leading biotech and pharmaceutical industry experts, academicians and decision makers who are passionate about addressing major global issues by turning ideas into solutions.

Why Attend?
Featuring world‑class plenary speakers, cross‑cutting educational talks, poster presentations by budding researchers, in addition to valuable networking and business development opportunities through exhibitions, partnering, branding, and B2B meetings. #VSBOSTON22 is a must‑attend event for the industry’s prominent and most promising companies.

Target Audience: C-level executives, scientists, presidents, VPs and SVPs, drug developers, academicians, manufacturers, researchers and developers, directors, healthcare professionals, regulatory specialists, and consultants.

Here are a few talks lined up for the 2022 meeting that share valuable first-hand insights into the realities of progressing viable vaccines:

• Accelerate the supply of vaccines to all populations worldwide by Mic McGoldrick, Associate Director Global CMC Policy, Merck
• Designing a Universal SARS-CoV-2 Vaccine Against Evolving Variants by Mark J. Newman, Chief Scientific Officer, GeoVax
• Pandemic to Endemic: COVID-19 and the Future for Global Health Vaccines by Jerome Kim, International Vaccine Institute
• Therapeutic combinations of immunotherapeutic vaccines for treatment of solid tumor by Joost Oppenheim, Head of Cellular Immunology, National Cancer Institute, NIH
• Recent advances in vaccine adjuvants by Derek O'Hagan, Senior Advisor Vaccines R&D, GSK
• Precision Vaccines by Ofer Levy, Director of Precision Vaccines Program, Boston Children's Hospital
• Next Generation Adjuvants for Improved Vaccines by Tyler Martin, Adjuvance Technologies
• Vaccine design exploiting immunity by Leonard Moise, Director of Vaccine Research, EpiVax
• Maternal Immunization for Protection of Neonates by Trudy Morrison, Professor, University of Massachusetts Medical School
• Why we miss: engineering universal vaccines targeting broadly neutralizing epitopes on polymorphic pathogens by Jacob Glanville, Founder, CEO & President, Centivax
• High Efficacy Malaria Vaccine by Adrian Hill, Director of the Jenner Institute, University of Oxford
• COVID-19 Vaccine and Autoimmune Diseases by Yehuda Shoenfeld, President, ARIEL University
• Vaccine Dosage Form Development via Spray Drying for Global Distribution by Reinhard Vehring, George Ford Chair in Materials Engineering, University of Alberta
• Protein-based vaccine against COVID-19 by Farshad Guirakhoo, Chief Scientific Officer, Vaxxinity
• Computational Approaches for Targeted Vaccine Design by Nikolay V. Dokholyan, Director of The Center for Translational Systems Research, Penn State College of Medicine

Register at https://biogatesc.com/events/va-cc-in-e/#tickets-section

Conference Dates: March 28-30, 2022
Conference Venue: Hilton Boston/Woburn 2 Forbes Road, Woburn, Massachusetts, 01801, USA
Conference Contact: [email protected] / [email protected]

https://biogatesc.com/events/va-cc-in-e/